USAID cuts shutter India's first clinic for transgender people
India's first medical clinic for transgender people has shut operations in three cities after US President Donald Trump stopped foreign aid to it.
Mitr (friend) Clinic, which was started in 2021 in the southern city of Hyderabad, offered HIV treatment, gender affirming support and counselling services to thousands of transgender people.
Two more Mitr Clinics in Thane and Pune cities in western India, which were established the same year, have also shut down due to the aid cut.
In January, Trump signed an executive order pausing all foreign aid for 90 days, pending a review.
Trump has said he wants overseas spending to be closely aligned with his "America First" approach.
His crackdown on USAID, the US agency overseeing humanitarian aid to foreign countries since the 1960s, has been seen as a step to this end.
The pausing of USAID funds has affected dozens of development programmes all around the world, especially in poor and developing countries.
In India, the shutting down of the Mitr Clinics has impacted the transgender community's access to crucial medical support.
The project came into existence under the US President's agency for AIDS Relief (PEPFAR) in 2003 when George Bush was president. John Hopkins University worked in collaboration with USAID and the Indian government to set it up.
A staff member who spoke on condition of anonymity to BBC Hindi said the three clinics catered to some 6,000 people and about 6% to 8% of the patients were being treated for HIV.
"All these cases were below 30 years of age. And 75% to 80% of this population was accessing health services for the first time," this staff member said.
In Hyderabad, the Mitr Clinic offered care to 150 to 200 transgender patients each month, many of whom suffered from HIV. The clinic had a small team of doctors, psychologists and technical staff.
"We were receiving 250,000 rupees ($2900; £2300) every month to provide services," Rachana Mudraboyina, a transwoman who was in-charge of the clinic, told BBC Hindi.
The news of the clinic's closure has come as a blow to the community.
Vyjayanti Vasanta Mogli, a transwoman who has visited the clinic, told The Indian Express newspaper that she was "devastated" by the news as the clinic used to offer treatment at subsidised rates.
Another transwoman, who was hoping to avail of the clinic's gender affirming services, told the Express that she was sad that she would no longer be able to do this.
India is estimated to have around two million transgender people, though activists say the number is higher. Despite a 2014 Supreme Court ruling that gives them the same rights as people of other genders, many still struggle to access education and healthcare due to stigma and discrimination.
There are state-run and private hospitals that offer medical help to the community, but many say they prefer going to Mitr Clinics because they find it more affordable and inclusive.
"Transgender people are not treated properly in general hospitals," Rachana says, explaining why the Mitr Clinics were so important for the community.
Trump's order freezing foreign aid has been criticised by many.
"USAID has made significant contributions in health and education and shutting it down is bound to have an impact on developing countries," Bubberjung Venkatesh, a lawyer, told BBC Hindi.
"It's a big blow. Its support for HIV prevention was significant," he added.
Last Thursday, the Trump administration said it was going to eliminate more than 90% of USAID's foreign aid contracts. This means that very few projects will survive and the Mitr Clinics are unlikely to be among them.
Elon Musk, a close aide of Trump who also heads a government department in charge of slashing federal spending and jobs, has criticised funding projects for transgender people.
"That's what American tax dollars were funding," Musk said in a post on X (formerly Twitter) on Friday in response to a post about the closure of the Mitr Clinics.
Meanwhile, staff at the clinic say they are looking for funding from other sources and hope that the state government will step in to help.
"We did a lot more than just provide medical help. The clinic also provided us a space to interact with the community, to share advice about various government schemes and health facilities," Rachana says.
"We want to continue [running the clinic] and are trying our best to find donors," she adds.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
an hour ago
- Bloomberg
FDA Pauses Trials of Gilead HIV Combination After Safety Signal
Gilead Sciences Inc. said federal regulators had placed on hold trials of a new experimental once-weekly HIV drug combination therapy after white blood cell counts dropped in some of the patients. The studies were testing two experimental HIV drugs, GS-1720 and GS-4182, when given together. Gilead said the Food and Drug Administration paused the trials due to a ' safety signal ' triggered by a decrease in lymphocyte levels in some patients given the therapy. Lymphocytes are a type of white blood cell that play a critical role in the immune system's ability to fight infections.


Politico
an hour ago
- Politico
Dr. Jay in the hot seat
Presented by Driving the day WHAT TO DO WITH NIH'S UNSPENT FUNDS — President Donald Trump's cuts to ideologically disfavored research have left the National Institutes of Health with unspent funds. Director Jay Bhattacharya, under pressure from critics on Capitol Hill and in the research community, is pledging to change that. 'The biomedical research enterprise is being refocused and that's what will keep America at the forefront of global science, safety, and innovation,' HHS spokesperson Andrew Nixon said in a statement. The administration, Nixon confirmed, has targeted research Trump opposes on issues like transgender health care and health disparities among people of different races. Whether critics are satisfied in the end will depend not only on whether Bhattacharya follows through on his promise, but also on how he decides to spend the money. Thus far, neither he nor anyone in the Trump administration have laid out a detailed plan. By the numbers: A New York Times analysis found that the NIH had spent about $1.6 billion less between the time Trump took office Jan. 20 and the end of April compared to the same period the year before. Bhattacharya told advocates for research last month that he'd spend all of the agency's $48 billion budget for this year by the end of September. In the hot seat: Democrats will get a chance to ask Bhattacharya for more details when he testifies before a Senate Appropriations subcommittee this morning. Thus far, they've focused more on the cuts than on where the money will go, reflecting their view that Trump and his Department of Government Efficiency wanted to slash government spending, not target that spending on different priorities. Trump's budget proposal, released last month, suggested as much with its call for a 40 percent reduction in the NIH's total budget. The NIH is putting $500 million into a universal vaccine, which will target multiple strains of a virus. It also recently solicited proposals for autism research, with $50 million on offer. Last month, when Bhattacharya's boss, Health and Human Services Secretary Robert F. Kennedy Jr., testified before a House Appropriations subcommittee, ranking Democrat Rosa DeLauro of Connecticut pressed him: 'Are you planning to break the law by impounding congressionally appropriated funds?' Kennedy said no: 'If Congress appropriates me the money, I'm going to spend the money.' WELCOME TO TUESDAY PULSE. I'm Robert King, POLITICO's CMS reporter, filling in for Kelly today. It will be a busy week for health policy wonks as we wait for more news on whether the Senate makes changes to Medicaid in the 'big beautiful bill.' If you have any tips or news, don't hesitate to shoot me a message. Send tips, scoops and general thoughts to rking@ and khooper@ Follow along @rking_19 and @Kelhoops. AROUND THE AGENCIES RFK'S BOLDEST VACCINE STEP YET — HHS Secretary Robert F. Kennedy Jr. made his most dramatic move yet to overhaul vaccine approvals, firing all 17 members of the panel that advises the Centers for Disease Control and Prevention on vaccines. Kennedy said in an opinion piece for The Wall Street Journal that the Advisory Committee on Immunization Practices is rife with conflicts of interest and has acted as a rubber stamp for vaccines. This is the latest step for Kennedy, who has questioned the safety and effectiveness of vaccines, in changing how vaccines are approved and recommended by the federal government. He said in the op-ed that his goal is to restore faith in vaccines. It will now be up to Kennedy to pick new members to serve four-year terms on the panel, which votes on updates to CDC's vaccine schedule. The CDC director can override the recommendation but rarely does. His decision appears to contradict a promise he made to Sen. Bill Cassidy (R-La.) to secure the senator's vote for confirmation. Kennedy had promised to maintain ACIP 'without changes,' according to a speech Cassidy made on the Senate floor announcing his support for the nomination. Cassidy responded to the firings, writing on X that 'now the fear is that ACIP will be filled up with people who know nothing about vaccines except suspicion.' He added that he spoke with Kennedy and will continue to speak with him 'to ensure this is not the case.' Cassidy — who chairs the Senate Health, Education, Labor and Pensions Committee — later told reporters that the assurance he got from Kennedy was on the ACIP process rather than who sits on the panel. Sen. Susan Collins (R-Maine), who voted for Kennedy and sits on HELP, was taken by surprise. 'I don't know who serves on those committees, but it seems to be excessive to ask for everybody's resignations,' she told reporters. Congress TRYING TO STOP MEDICAID CUTS — More than 700 nursing home and assisted living professionals are heading to Capitol Hill this week to push lawmakers to avoid cuts to Medicaid in Republicans' megabill. The nursing home trade group American Health Care Association and National Center for Assisted Living will hold its annual congressional briefing this week. The fly-in day coincides with the last chance for advocates to push lawmakers for changes to the megabill. The group released a survey Monday of 363 nursing homes that found 79 percent were extremely concerned about Medicaid cuts. Another 55 percent would have to reduce their Medicaid patient population. One of the issues is a moratorium on provider taxes. A state can levy a tax on hospitals or other providers to pay for its share of Medicaid, which it jointly funds with the federal government. Under Medicaid, a state can get a higher payment from the federal government if it devotes more of its own resources. A state can use its provider tax revenue to get a higher federal payment and can replace the taxed amount from hospitals or nursing homes through a higher payment rate. The moratorium placed in the megabill, which passed the House last month, enables current provider taxes to continue but freezes any new rates. House Republicans have argued the taxes are a loophole that enable states to get more federal money, but the AHCA argued they are vital to keep nursing homes afloat. 'Restricting provider taxes is restricting resources to seniors and their caregivers,' said Clif Porter, president and CEO of the AHCA, in a statement. White House MCDONALDS, PEPSI HEAD TO WHITE HOUSE — The White House invited nearly 50 food industry and farm groups as well as major companies mentioned in a controversial report on how to Make America Health Again to meet with officials, POLITICO's Grace Yarrow reports. The list of invitees for the series of meetings includes lobbying heavyweights such as the National Cattlemen's Beef Association and American Farm Bureau Federation. Other invitees include soda brands Coca-Cola and Pepsi, as well as fast food representatives McDonald's and Yum! Brands, which own Taco Bell, KFC and others. The meetings are expected to take place this week and next. A May report from the MAHA Commission bashed farm groups for pesticide use. HHS has also called for a ban on sodas in federal nutrition programs. 'We're all very interested to see how these meetings play out over the next week and if it is a meaningful gesture or not,' said one agriculture industry insider. 'Is this just an exercise in placating stakeholders?' WHAT WE'RE READING The Washington Post reports on why Texas is spending millions to research an illegal psychedelic to jumpstart clinical trials. POLITICO's Benjamin Guggenheim reports on how Senate Finance Chair Mike Crapo is maneuvering behind closed doors to get his party's massive bill through the chamber. KFF Health News reports on when cannabis users age their health risks appear to grow.
Yahoo
2 hours ago
- Yahoo
LGBTQ+ patients stay up-to-date on preventive care when their doctors are supportive, saving money and lives throughout society
When LGBTQ+ patients are unsure if they can be open about their identity and related health needs, it becomes more difficult for them to access high-quality health care. In our recently published research, my colleagues and I found that how LGBTQ+ people are treated at the doctor's office has a measurable effect on whether they stay up to date with lifesaving preventive care like flu shots, colorectal cancer screenings and HIV testing. We examined how LGBTQ+ adults rated their health care provider across three areas: LGBTQ+ cultural competency, such as if providers used inclusive language on forms and in person; LGBTQ+ clinical competency, such as their doctor's knowledge on all aspects of their health; and experiences of discrimination, such as being told to seek care elsewhere. After analyzing survey data on the experiences of more than 950 LGBTQ+ adults from across the U.S., we saw that three clear patterns emerged. First, 34% of participants reported having positive health care experiences – meaning their providers were culturally and clinically competent about LGBTQ+ health needs, and did not discriminate against them. These patients were more likely to be up to date on at least one preventive service recommended by the U.S. Preventive Services Task Force, compared to those receiving neutral or discriminatory care. Second, 60% of participants reported having neutral experiences, when their providers were clinically competent about LGBTQ+ health needs and didn't discriminate against them, but were not culturally competent. These patients were 43% less likely to get an HIV test compared to patients reporting affirming care. Third, 6% of participants reported experiencing discrimination, when their providers were neither culturally nor clinically competent on LGBTQ+ health. These patients were 24% less likely to get a colorectal cancer screening compared to patients reporting affirming care. Most LGBTQ+ adults in our study reported neutral or even discriminatory care, which leads to avoidable health risks and higher costs for the health system. This provides additional evidence that being supportive of LGBTQ+ patients has measurable improvements for health outcomes. Preventive care saves lives and saves money. When diseases like colorectal cancer or HIV are caught early, treatments are often simpler, more effective and less expensive. When LGBTQ+ patients are made to feel unwelcome or unsafe, we found that they are less likely to get routine preventive care, ultimately driving up long-term costs across the health system. States like North Carolina and Georgia that have more health systems participating in the Human Rights Campaign's Healthcare Equality Index, which evaluates policies and practices around LGBTQ+ care, had higher rates of LGBTQ+ patients reporting positive care experiences compared to states with few participating health systems, such as Tennessee and Alabama. Other researchers have found that health systems participating in the Healthcare Equality Index have lower rates of nurse burnout and better quality of care, along with higher patient satisfaction among all patients. This study was originally funded by the National Institute on Aging, but it was among the first LGBTQ+-focused projects terminated by the Trump administration in its efforts to eliminate 'gender ideology.' Our team has continued the work independently to ensure that the over 1,250 participants who already shared their experiences and data would not have this information sit idly. Our findings reinforce what many LGBTQ+ patients already know – nonjudgmental and competent care is not a luxury, but a public health necessity. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Nathaniel M. Tran, University of Illinois Chicago Read more: Anti-LGBTQ+ policies harm the health of not only LGBTQ+ people, but all Americans Heteronormativity in health care is harmful for LGBTQ+ patients – and a source of tension for queer and trans doctors Our trans health study was terminated by the government – the effects of abrupt NIH grant cuts ripple across science and society Nathaniel M. Tran received funding from the National Institute on Aging and Vanderbilt University.